Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program-Reference-Cited by-同舟云学术

Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program

Published:2017-02-22 Issue:6 Volume:11 Page:593-601
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Gray E¹,O’Leary A²³,Bergin C¹⁴,Cannon M⁵,Courtney G⁶,Crosbie O⁷,De Gascun CF⁸,Fanning L J⁹,Feeney E¹⁰,Houlihan DD¹⁰,Kelleher B¹¹,Lambert J S¹¹¹²,Lee J¹³,Mallon PWG¹¹¹²,McConkey S⁵,McCormick A¹⁰,McKiernan S⁴,McNally C⁵,Murray F⁵,Sheehan G¹¹,Stewart S¹¹,Walsh C¹⁴,Norris S¹⁴

Affiliation:

1. School of Medicine, Trinity College Dublin, Dublin, Ireland

2. National Centre for Pharmacoeconomics, St. James’ Hospital, Dublin, Ireland

3. School of Pharmacy, Royal College of Surgeons of Ireland, Dublin, Ireland

4. St James’ Hospital, Dublin, Ireland

5. Beaumont Hospital, Dublin, Ireland

6. St. Luke’s Hospital, Kilkenny, Ireland

7. Cork University Hospital, Cork, Ireland

8. National Virus Reference Laboratory, University College Dublin, Dublin, Ireland

9. Molecular Virology Diagnostic & Research Laboratory, Department of Medicine, University College Cork, Cork, Ireland

10. St. Vincent’s University Hospital, Dublin, Ireland

11. Mater Misericordiae University Hospital, Dublin, Ireland